FLUO.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$165803	—	$-5.92	$-5.92–$-5.92	—	1
2027	$11M	+6664.5%	$-7.04	$-7.04–$-7.04	—	1
2028	$0	-100.0%	$-12.77	$-12.77–$-12.77	—	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

DCF fair valuemodel estimate

Intrinsic value

$2.51

Price

$33.40

Implied downside

-92%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
FLUO.STFluoGuide A/S	$33.40	+0.60%	$546M	—
ADDV-B.STADDvise Group AB (publ)	$1.73	+0.58%	$1.0B	—
BACTI-B.STBactiguard Holding AB (publ)	$15.65	-2.19%	$548M	—
CLBIO.STCorline Biomedical AB	$15.15	-0.33%	$396M	—
DOXA.STDoxa AB	$0.34

FluoGuide A/S

FluoGuide A/S is a Danish life science company dedicated to developing and commercializing advanced surgical solutions. Its flagship investigational compound, FG001, is currently undergoing Phase I/II clinical trials for the treatment of high-grade glioma (a type of brain cancer) and has also advanced to Phase II development for lung cancer. The company is further developing FG002, a preclinical-stage product that utilizes novel uPAR-targeted luminescent technology to enable surgeons to distinguish cancerous from healthy tissue during operations. FluoGuide A/S has established key collaborations, including an agreement with Linköping University Hospital to support the Phase I/II clinical evaluation of FG001 for the surgical removal of brain tumors, and an ongoing partnership with Copenhagen University Hospital. The company was founded in 2018 and maintains its headquarters in Copenhagen, Denmark.

fluoguide.com

Employees: 7
IPO / List date: Jun 17, 2019
HQ: DK

Held by traders on TradeandTell

No one on the platform currently holds FLUO.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in FLUO.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded FLUO.ST yet.